Novo Nordisk Ozempic is a prescription GLP-1 drug for type 2 diabetes. Learn how it works, what it costs per month, and side effects to know.
Ozempic is a once-weekly injectable prescription medicine made by Novo Nordisk that contains semaglutide, a GLP-1 receptor agonist. The FDA approved Ozempic for adults with type 2 diabetes, and it is not approved as a general weight-loss drug. Knowing who makes it, how it works, and what it costs helps you ask sharper questions at your next appointment.
What Is Novo Nordisk Ozempic?
Ozempic is the brand name Novo Nordisk uses for semaglutide injections. It is approved to help adults with type 2 diabetes control blood sugar alongside diet and exercise.
It is also approved to lower the risk of heart attack, stroke, and death in adults who have type 2 diabetes plus known cardiovascular disease. That heart benefit is uncommon among older diabetes drugs, and it is one reason prescribers reach for it.
Ozempic is not the same product as Wegovy, even though both are semaglutide injections. The maximum doses differ, and so do the FDA-approved indications.
Who Makes Ozempic? Inside the Manufacturer
The manufacturer behind the drug is novo nordisk, a Danish pharmaceutical company that has focused on diabetes and metabolic disease for roughly a century. Novo Nordisk also produces insulin, oral GLP-1 tablets, and weight-management therapies.
That lineup of novo nordisk products includes Ozempic, Rybelsus, Wegovy, Victoza, Saxenda, and several insulin brands. Novo Nordisk is not a pharmacy, however, and it does not fill consumer prescriptions directly in the United States; your prescription is dispensed by a retail or mail-order pharmacy.
How Ozempic Works in the Body
Semaglutide mimics GLP-1, a hormone your gut releases after you eat. It slows how quickly food leaves the stomach, signals the pancreas to release insulin when blood sugar rises, and reduces the amount of glucagon the body produces.
Those same actions tend to curb appetite, which is why many people lose weight while taking it. That effect is also why some clinicians prescribe it off-label for weight management, even though that is not its approved use.
Dosing usually starts at 0.25 mg once weekly and increases about every four weeks. The 0.25 mg step is a starter dose that rarely moves blood sugar much; it mainly lets the body adjust.
How Novo Nordisk GLP-1 Products Compare
Novo Nordisk sells several related medicines that are easy to confuse. The table below compares the most common options.
| Brand | Active ingredient | FDA-approved use | Typical adult dose |
|---|---|---|---|
| Ozempic | Semaglutide injection | Type 2 diabetes; cardiovascular risk reduction | 0.25 mg weekly, titrated up to 2 mg weekly |
| Wegovy | Semaglutide injection | Chronic weight management | 0.25 mg weekly, titrated up to 2.4 mg weekly |
| Rybelsus | Semaglutide tablet | Type 2 diabetes | 3 mg daily, titrated up to 14 mg daily |
| Saxenda | Liraglutide injection | Chronic weight management | 0.6 mg daily, titrated up to 3 mg daily |
Doses and indications above follow FDA labeling. Only a licensed prescriber can decide which option fits a specific patient.
What You Pay Toward the Cost of Ozempic Per Month
What you pay toward the cost of ozempic per month depends heavily on your insurance plan. Without coverage, the list price has run roughly $950 to $1,000 per month in the United States, before any discount programs.
Real-world out-of-pocket amounts vary widely:
- Commercial insurance: often a tiered copay, sometimes $25 to $100 per month once prior authorization is approved.
- Medicare Part D: copays depend on the plan and coverage phase, and manufacturer savings cards generally cannot be used.
- Medicaid and other government plans: savings cards are typically excluded.
- No insurance: the full list price usually applies unless a patient assistance program is available.
Eligible patients with commercial coverage may qualify for an ozempic coupon through the manufacturer savings card, which can cap out-of-pocket costs at a set monthly amount. Program rules and prices change, so confirm current details before you fill a prescription.
Ozempic Side Effects and Safety
Most people notice gastrointestinal symptoms first. Nausea, vomiting, diarrhea, constipation, and stomach pain are the most frequently reported reactions, and they often ease as the body adjusts.
More serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and worsening diabetic retinopathy. Ozempic carries a boxed warning about thyroid C-cell tumors seen in rodents, and it should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN2.
In clinical trials, reported ozempic side effects in females are broadly similar to those in males, though women tend to report nausea and vomiting somewhat more often. Some women also describe changes in menstrual patterns; that link is not well established and deserves a conversation with a clinician.
Ozempic is not recommended during pregnancy, and people who are breastfeeding or planning a pregnancy should discuss alternatives. This article is general information, not medical advice.
Questions to Ask Before Starting
- Are my kidney and liver function results normal enough for this medicine?
- Do I have any history of pancreatitis or gallbladder problems?
- Will my plan require prior authorization, and what happens if it is denied?
- What is the plan if I cannot tolerate the starting dose?
Other options exist, including tirzepatide brands and oral semaglutide, and investigational drugs such as retatrutide are still being studied. A healthcare professional can help weigh benefits against risks for your situation.
Frequently Asked Questions
Is Ozempic made by Novo Nordisk?
Yes. Ozempic is manufactured by Novo Nordisk, a Danish pharmaceutical company, and its active ingredient is semaglutide. The same company markets semaglutide under the brand name Wegovy for chronic weight management.
How much does Ozempic cost per month without insurance?
The list price for Ozempic in the United States is roughly $950 to $1,000 per month without insurance. Patients with commercial coverage often pay a set copay through the manufacturer savings card, while people on government insurance are usually excluded from those programs.
Is Ozempic FDA-approved for weight loss?
No. Ozempic is FDA-approved for type 2 diabetes and for lowering cardiovascular risk in adults who have type 2 diabetes and heart disease. Wegovy, which contains the same active ingredient at a higher maximum dose, is the Novo Nordisk product approved for chronic weight management.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.